Cardiol Therapeutics Statistics

Total Valuation

TSX:CRDL has a market cap or net worth of CAD 202.49 million. The enterprise value is 174.93 million.

Market Cap	202.49M
Enterprise Value	174.93M

Important Dates

The next estimated earnings date is Thursday, May 21, 2026.

Earnings Date	May 21, 2026
Ex-Dividend Date	n/a

Share Statistics

TSX:CRDL has 111.87 million shares outstanding. The number of shares has increased by 24.11% in one year.

Current Share Class	111.87M
Shares Outstanding	111.87M
Shares Change (YoY)	+24.11%
Shares Change (QoQ)	+11.28%
Owned by Insiders (%)	3.05%
Owned by Institutions (%)	11.72%
Float	93.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	8.37
P/TBV Ratio	8.37
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.81
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.21

Financial Position

The company has a current ratio of 4.39, with a Debt / Equity ratio of 0.00.

Current Ratio	4.39
Quick Ratio	3.93
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.00
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -173.96% and return on invested capital (ROIC) is -105.79%.

Return on Equity (ROE)	-173.96%
Return on Assets (ROA)	-78.25%
Return on Invested Capital (ROIC)	-105.79%
Return on Capital Employed (ROCE)	-146.60%
Weighted Average Cost of Capital (WACC)	6.58%
Revenue Per Employee	n/a
Profits Per Employee	-2.02M
Employee Count	18
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.77% in the last 52 weeks. The beta is 0.42, so TSX:CRDL's price volatility has been lower than the market average.

Beta (5Y)	0.42
52-Week Price Change	+16.77%
50-Day Moving Average	1.74
200-Day Moving Average	1.54
Relative Strength Index (RSI)	48.25
Average Volume (20 Days)	113,213

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-35.59M
Pretax Income	-36.35M
Net Income	-36.35M
EBITDA	-35.55M
EBIT	-35.59M
Earnings Per Share (EPS)	-0.39

Full Income Statement

Balance Sheet

The company has 27.67 million in cash and 116,408 in debt, with a net cash position of 27.56 million or 0.25 per share.

Cash & Cash Equivalents	27.67M
Total Debt	116,408
Net Cash	27.56M
Net Cash Per Share	0.25
Equity (Book Value)	24.20M
Book Value Per Share	0.22
Working Capital	24.14M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -24.22 million and capital expenditures -60,130, giving a free cash flow of -24.28 million.

Operating Cash Flow	-24.22M
Capital Expenditures	-60,130
Depreciation & Amortization	39,722
Net Borrowing	-55,376
Free Cash Flow	-24.28M
FCF Per Share	-0.22

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSX:CRDL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.11%
Shareholder Yield	-24.11%
Earnings Yield	-17.95%
FCF Yield	-11.99%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2